Zepp Health Corporation (ZEPP)
NYSE: ZEPP · IEX Real-Time Price · USD
0.898
-0.002 (-0.26%)
Apr 15, 2024, 4:00 PM EDT - Market closed

Zepp Health Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Year 20222021202020192018201720162015
Revenue
4,1436,2506,4335,8123,6452,0491,556896.46
Revenue Growth (YoY)
-33.72%-2.85%10.69%59.44%77.92%31.64%73.63%-
Cost of Revenue
3,3404,9445,1014,3452,7061,5541,280785.87
Gross Profit
803.121,3061,3331,468939.45494.7276.15110.59
Selling, General & Admin
696.24696.62620.46430.44310.51158.91130.4789.15
Research & Development
517.12515.08538.01430.82263.22153.83132.361.55
Operating Expenses
1,2131,2121,158861.26573.73312.73262.77150.71
Operating Income
-410.2493.94174.2606.48365.72181.9713.38-40.11
Interest Expense / Income
5744.8822.6200000
Other Expense / Income
-113.06-99.49-108.33-46.6-26.36-13.32-13.65-1.36
Pretax Income
-354.18148.55259.91653.08392.08195.2927.03-38.75
Income Tax
-65.8810.7531.1577.8952.0427.613.09-0.9
Net Income
-288.31137.8228.75575.2340.05167.6823.95-37.85
Preferred Dividends
0002.45226.56121.5636.0723.4
Net Income Common
-288.31137.8228.75572.75113.4946.12-12.12-61.25
Net Income Growth
--39.76%-60.06%404.67%146.08%---
Shares Outstanding (Basic)
246252248244212685650
Shares Outstanding (Diluted)
246264260256225765650
Shares Change
-6.84%1.54%1.72%13.74%194.97%37.18%11.14%-
EPS (Basic)
-4.682.203.689.402.162.72-0.88-4.88
EPS (Diluted)
-4.682.083.528.962.042.60-0.88-4.88
EPS Growth
--40.91%-60.71%339.22%-21.54%---
Free Cash Flow
-795.78-275.9773.75393.72690.47217.056.99-9.68
Free Cash Flow Per Share
-12.93-4.381.196.4613.0412.810.50-0.77
Dividend Per Share
0.100-------
Gross Margin
19.39%20.89%20.71%25.25%25.77%24.14%17.74%12.34%
Operating Margin
-9.90%1.50%2.71%10.43%10.03%8.88%0.86%-4.47%
Profit Margin
-6.96%2.20%3.56%9.85%3.11%2.25%-0.78%-6.83%
Free Cash Flow Margin
-19.21%-4.42%1.15%6.77%18.94%10.59%0.45%-1.08%
Effective Tax Rate
-7.23%11.99%11.93%13.27%14.14%11.42%-
EBITDA
-197.99286.85357.85697.98398.3199.0129.43-38.47
EBITDA Margin
-4.78%4.59%5.56%12.01%10.93%9.71%1.89%-4.29%
Depreciation & Amortization
99.1993.4275.3244.96.223.722.40.29
EBIT
-297.18193.43282.53653.08392.08195.2927.03-38.75
EBIT Margin
-7.17%3.09%4.39%11.24%10.76%9.53%1.74%-4.32%
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).